Literature DB >> 466412

GABA-accumulating neurons in the nucleus raphe dorsalis and periaqueductal gray in the rat: a biochemical and radioautographic study.

M F Belin, M Aguera, M Tappaz, A McRae-Degueurce, P Bobillier, J F Pujol.   

Abstract

The possibility of a GABAergic innervation of the nucleus raphe dorsalis (NRD) has been investigated by using the following approaches: (i) the identification of the principal neuronal groups afferent to the NDR by using horseradish peroxidase retrograde transport, (ii) the determination of glutamate decarboxylase activity (GAD) in the NRD after lesioning these groups or their putative pathways, and (iii) the radioautographic identification of terminals axons and nerve cells accumulating intraventricularly injected [3H]GABA. The hypothesis of a local GABAergic network is supported by the failure to obtain important changes in GAD after lesions of NRD afferents and the presence in this nucleus of terminals, fibers and nerve cell bodies accumulating [3H]GABA. It appears that these GABA-accumulating neurons could represent a portion of aperiventricular GABAergic system in the periaqueductal gray and the pontine ventricular gray.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 466412     DOI: 10.1016/0006-8993(79)90107-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

1.  GABA and behavioral inhibition in the neonatal rat pup.

Authors:  L P Spear; J Penson; D G Linville
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 2.  Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence.

Authors:  Subimal Datta; Robert Ross Maclean
Journal:  Neurosci Biobehav Rev       Date:  2007-03-12       Impact factor: 8.989

3.  Presynaptic gating of excitation in the dorsal raphe nucleus by GABA.

Authors:  Mariano Soiza-Reilly; Wayne B Anderson; Christopher W Vaughan; Kathryn G Commons
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

4.  gamma-Aminobutyric acid responses in rat locus coeruleus neurones in vitro: a current-clamp and voltage-clamp study.

Authors:  S S Osmanović; S A Shefner
Journal:  J Physiol       Date:  1990-02       Impact factor: 5.182

Review 5.  Collateralized dorsal raphe nucleus projections: a mechanism for the integration of diverse functions during stress.

Authors:  Maria Waselus; Rita J Valentino; Elisabeth J Van Bockstaele
Journal:  J Chem Neuroanat       Date:  2011-05-30       Impact factor: 3.052

6.  Lateral habenula and hippocampus: a complex interaction raphe cells-mediated.

Authors:  G Ferraro; M E Montalbano; P Sardo; V La Grutta
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

7.  Atp13a2 expression in the periaqueductal gray is decreased in the Pink1 -/- rat model of Parkinson disease.

Authors:  Cynthia A Kelm-Nelson; Sharon A Stevenson; Michelle R Ciucci
Journal:  Neurosci Lett       Date:  2016-04-04       Impact factor: 3.046

8.  Modification of the antinociceptive effect of morphine by centrally administered diazepam and midazolam.

Authors:  P Mantegazza; M Parenti; R Tammiso; P Vita; F Zambotti; N Zonta
Journal:  Br J Pharmacol       Date:  1982-04       Impact factor: 8.739

9.  Depression-like behavior in rat: Involvement of galanin receptor subtype 1 in the ventral periaqueductal gray.

Authors:  Peng Wang; Hui Li; Swapnali Barde; Ming-Dong Zhang; Jing Sun; Tong Wang; Pan Zhang; Hanjiang Luo; Yongjun Wang; Yutao Yang; Chuanyue Wang; Per Svenningsson; Elvar Theodorsson; Tomas G M Hökfelt; Zhi-Qing David Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-25       Impact factor: 11.205

10.  Studies on the interaction between cerebral 5-hydroxytryptamine and gamma-aminobutyric acid in the mode of action of diazepam in the rat.

Authors:  J Collinge; C J Pycock; P V Taberner
Journal:  Br J Pharmacol       Date:  1983-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.